Citation Impact
Citing Papers
Imaging Tetrahymena ribozyme splicing activity in single live mammalian cells
2003 StandoutNobel
The Immunology of Fibrosis
2013
Immunomodulatory properties of mesenchymal stromal cells
2007 Standout
The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis
2006
PDGF-C Induces Maturation of Blood Vessels in a Model of Glioblastoma and Attenuates the Response to Anti-VEGF Treatment
2009
Nephrotic Syndrome After Bevacizumab: Case Report and Literature Review
2007
Osteoporosis
2019 Standout
Acute kidney injury
2012 Standout
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury
2017
Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury
2009
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Developing aptamers into therapeutics
2000
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Angiogenesis in cancer and other diseases
2000 StandoutNature
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
The biology of VEGF and its receptors
2003 Standout
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
Statins for prevention of contrast‐induced nephropathy in patients undergoing non‐emergent percutaneous coronary intervention
2009
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
2006 Standout
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Angiogenesis in health and disease
2003 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Regulation of PDGF and its receptors in fibrotic diseases
2004
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Diabetic Retinopathy
2012 Standout
Pro-fibrogenic potential of PDGF-D in liver fibrosis
2007
Development of DNA aptamers using Cell-SELEX
2010
Aptamers as therapeutic and diagnostic agents
2000
Pre-eclampsia
2005 Standout
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
2002
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Structural and functional specificities of PDGF‐C and PDGF‐D, the novel members of the platelet‐derived growth factors family
2005
Neural tissue engineering options for peripheral nerve regeneration
2014
Aptamers as tools for target validation
2005
Vascular Endothelial Growth Factor Enhances Glomerular Capillary Repair and Accelerates Resolution of Experimentally Induced Glomerulonephritis
2001
Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria
2003
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Clinical applications of angiogenic growth factors and their inhibitors
1999
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 Standout
Unfolded phosphopolypeptides enable soft and hard tissues to coexist in the same organism with relative ease
2013
Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR
1999
Emerging clinical applications of RNA
2002 Nature
Mechanisms of angiogenesis and arteriogenesis
2000 Standout
Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
2003
Nucleic Acid Aptamers as Tools and Drugs: Recent Developments
2003
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
Pegaptanib for Neovascular Age-Related Macular Degeneration
2004 Standout
VEGF Inhibition and Renal Thrombotic Microangiopathy
2008 Standout
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes?the EURODIAB Prospective Complications Study
2005
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury
2003 Standout
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer
2003
Angiogenesis as a therapeutic target
2005 StandoutNature
Aptamers against extracellular targets for in vivo applications
2005
Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia
2005
Circulating Angiogenic Factors and the Risk of Preeclampsia
2004 Standout
Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia
2004
Latest Advances in Understanding Preeclampsia
2005 StandoutScience
Aptamers: An Emerging Class of Therapeutics
2005
Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia
2005
Effect of Pravastatin on Rate of Kidney Function Loss in People With or at Risk for Coronary Disease
2005
Functional Nucleic Acid Sensors
2009 Standout
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Advanced Glycation End Products
2006 Standout
Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells
1997
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Acute kidney injury: a springboard for progression in chronic kidney disease
2010
Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views
2007 Standout
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
2017
Efficacy of Short-Term High-Dose Atorvastatin for Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography
2010
Stromal Cell–Derived Factor-1α and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor
2005 StandoutNobel
Informational Complexity and Functional Activity of RNA Structures
2004 StandoutNobel
Live-Cell Labeling of Specific Protein Glycoforms by Proximity-Enhanced Bioorthogonal Ligation
2015 StandoutNobel
Functional Aptamers and Aptazymes in Biotechnology, Diagnostics, and Therapy
2007
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Peptide blockade of HIFα degradation modulates cellular metabolism and angiogenesis
2002 StandoutNobel
VEGF164Is Proinflammatory in the Diabetic Retina
2003
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Bevacizumab: An Angiogenesis Inhibitor with Efficacy in Colorectal and Other Malignancies
2004
Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes
2003
Works of Uta Kunter being referenced
Mesenchymal Stem Cells Prevent Progressive Experimental Renal Failure but Maldifferentiate into Glomerular Adipocytes
2007
A Fully Human Monoclonal Antibody (CR002) Identifies PDGF-D as a Novel Mediator of Mesangioproliferative Glomerulonephritis
2003
Antagonism of PDGF-D by Human Antibody CR002 Prevents Renal Scarring in Experimental Glomerulonephritis
2006
Peripheral Blood Tyrosinase Messenger RNA Detection and Survival in Malignant Melanoma
1996
Postischemic Acute Renal Failure Is Reduced by Short-Term Statin Treatment in a Rat Model
2002
A Novel, Dual Role of CCN3 in Experimental Glomerulonephritis
2012
Transplanted Mesenchymal Stem Cells Accelerate Glomerular Healing in Experimental Glomerulonephritis
2006
Early Mechanisms of Renal Injury in Hypercholesterolemic or Hypertriglyceridemic Rats
2000
Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes
2000
PDGF-C Is a Proinflammatory Cytokine that Mediates Renal Interstitial Fibrosis
2008
Specific Antagonism of PDGF Prevents Renal Scarring in Experimental Glomerulonephritis
2001
Tumour microdissemination and survival in metastatic melanoma.
2001
Exposure to Uremic Serum Induces a Procalcific Phenotype in Human Mesenchymal Stem Cells
2011
VEGF165 mediates glomerular endothelial repair
1999
The Effects of Platelet-Derived Growth Factor Antagonism in Experimental Glomerulonephritis Are Independent of the Transforming Growth Factor–β System
2002
Osteogenesis of Heterotopically Transplanted Mesenchymal Stromal Cells in Rat Models of Chronic Kidney Disease
2013